ClinicalTrials.govpublic full text
Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19
covid-19 pneumonia, nk cells, cell therapy, allogeneic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 911684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.